U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606833) titled 'The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori' on May 19.
Brief Summary: This is a multicenter, randomized, double blind, double-simulated, parallel control of positive drug phase III clinical study to evaluate the efficacy and safety of Anaprazole versus Esomeprazole-containing Bismuth quadruple therapy for eradication of Helicobacter pylori in China.
Study Start Date: June 10
Study Type: INTERVENTIONAL
Condition:
HELICOBACTER PYLORI INFECTIONS
Intervention:
DRUG: Anaprazole Sodium enteric-...